Clinical Trial Update: Open-label Single-arm Study to Assess the Efficacy of Mirikizumab in Patients With Inflammatory Strictures Due to CD [Phase 4]

View source ↗

Summary

An open-label, single-arm Phase 4 trial assessing the efficacy of mirikizumab in inflammatory strictures due to Crohn disease; currently NOT_YET_RECRUITING.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Crohn Disease

Drugs mentioned

• Mirikizumab (mirikizumab)

Snippet

Sponsor: Alimentiv Inc. | Conditions: Crohn Disease | Phase 4 | Status: NOT_YET_RECRUITING